Colorcon expands manufacturing and completes renovation of North America campus
The investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products.
Colorcon has completed a major expansion and renovation project at its North America production facility in West Point, Pennsylvania.
The multimillion-dollar investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products throughout the US, Canada, Puerto Rico, Mexico, Colombia, Peru, Bolivia as well as the northern areas of Central and Latin America.
Simon Tasker, President Americas region explains: “The investment in our West Point, US facility brings together expanded material warehousing and new best-in-class quality control laboratories to the existing production capabilities. This supports our future growth expectations, improves our environmental footprint and reduces supply lead times for our customers.”
Colorcon’s investment sees the consolidation of multiple legacy buildings into one, unified, manufacturing campus which will eliminate the need for off-site warehousing. The merging of these facilities will provide customers with the highest level of traceability on raw materials and finished goods produced at the site. There are also environmental benefits through the reduced transportation of materials between sites, diminishing traffic and noise in the area that surrounds the Colorcon property.
Martti Hedman, Colorcon CEO adds: “Colorcon’s West Point, Pennsylvania, site is one of seven film coating manufacturing sites strategically located around the world and is an important component in Colorcon’s Business Continuity Plan. This multi-year investment helps Colorcon to further improve its service to the customers and is a good example of how Colorcon invests in new capacity ahead of demand.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance